480 related articles for article (PubMed ID: 23264096)
1. All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART).
Kim JH; Psevdos G; Gonzalez E; Singh S; Kilayko MC; Sharp V
Infection; 2013 Apr; 41(2):545-51. PubMed ID: 23264096
[TBL] [Abstract][Full Text] [Related]
2. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
[TBL] [Abstract][Full Text] [Related]
3. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
Palella FJ; Baker RK; Moorman AC; Chmiel JS; Wood KC; Brooks JT; Holmberg SD;
J Acquir Immune Defic Syndr; 2006 Sep; 43(1):27-34. PubMed ID: 16878047
[TBL] [Abstract][Full Text] [Related]
4. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.
Krentz HB; Kliewer G; Gill MJ
HIV Med; 2005 Mar; 6(2):99-106. PubMed ID: 15807715
[TBL] [Abstract][Full Text] [Related]
5. [In-hospital mortality in HIV-infected patients: 10 years after the implementation of universal access to HAART in Mexico].
Martín-Onraet A; Piñeirua-Menéndez A; Perales-Martínez D; Ortega-Pérez R; Barrera-García A; Sierra-Madero J; Volkow-Fernández P
Salud Publica Mex; 2015; 57 Suppl 2():s163-70. PubMed ID: 26545132
[TBL] [Abstract][Full Text] [Related]
6. Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital.
Mzileni MO; Longo-Mbenza B; Chephe TJ
Pol Arch Med Wewn; 2008 Oct; 118(10):548-54. PubMed ID: 19112815
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with mortality among HIV-infected patients in the era of highly active antiretroviral therapy in southern India.
Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Yephthomi T; Pradeep A; Saghayam S; Flanigan T; Mayer KH; Solomon S
Int J Infect Dis; 2010 Feb; 14(2):e127-31. PubMed ID: 19632872
[TBL] [Abstract][Full Text] [Related]
8. Impact of HAART on causes of death of persons with late-stage AIDS.
Sansone GR; Frengley JD
J Urban Health; 2000 Jun; 77(2):166-75. PubMed ID: 10855998
[TBL] [Abstract][Full Text] [Related]
9. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000.
Jain MK; Skiest DJ; Cloud JW; Jain CL; Burns D; Berggren RE
Clin Infect Dis; 2003 Apr; 36(8):1030-8. PubMed ID: 12684916
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy.
Wolff AJ; O'Donnell AE
Chest; 2001 Dec; 120(6):1888-93. PubMed ID: 11742918
[TBL] [Abstract][Full Text] [Related]
11. Causes and pattern of mortality in HIV-infected, hospitalized patients in a tertiary care hospital: a fourteen year study.
Teja VD; Sudha T; Lakshmi V
Indian J Med Sci; 2007 Oct; 61(10):555-61. PubMed ID: 17932446
[TBL] [Abstract][Full Text] [Related]
12. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.
Lewden C; Salmon D; Morlat P; Bévilacqua S; Jougla E; Bonnet F; Héripret L; Costagliola D; May T; Chêne G;
Int J Epidemiol; 2005 Feb; 34(1):121-30. PubMed ID: 15561752
[TBL] [Abstract][Full Text] [Related]
13. Causes of death and factors associated with early death among human immunodeficiency virus (HIV)-infected persons in Singapore: pre-highly active antiretroviral therapy (HAART) and Peri-HAART.
Chow A; Tey J; Win MK; Leo YS
Ann Acad Med Singap; 2012 Dec; 41(12):563-70. PubMed ID: 23303113
[TBL] [Abstract][Full Text] [Related]
14. Trends and characteristics of all-cause mortality among HIV-infected inpatients during the HAART era (2006-2015) in Shanghai, China.
Ji Y; Wang Z; Shen J; Chen J; Yang J; Qi T; Song W; Tang Y; Liu L; Shen Y; Zhang R; Lu H
Biosci Trends; 2017 Mar; 11(1):62-68. PubMed ID: 28132999
[TBL] [Abstract][Full Text] [Related]
15. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
[TBL] [Abstract][Full Text] [Related]
16. Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy.
Floris-Moore M; Lo Y; Klein RS; Budner N; Gourevitch MN; Moskaleva G; Schoenbaum EE
J Acquir Immune Defic Syndr; 2003 Nov; 34(3):331-7. PubMed ID: 14600580
[TBL] [Abstract][Full Text] [Related]
17. AIDS-related opportunistic illnesses and early initiation of HIV care remain critical in the contemporary HAART era: a retrospective cohort study in Taiwan.
Lee CY; Tseng YT; Lin WR; Chen YH; Tsai JJ; Wang WH; Lu PL; Tsai HC
BMC Infect Dis; 2018 Jul; 18(1):352. PubMed ID: 30055564
[TBL] [Abstract][Full Text] [Related]
18. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
19. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcomes of patients admitted to a tertiary academic hospital in Pretoria with HIV and severe pneumonia: a retrospective cohort study.
Ueckermann V; Janse van Rensburg L; Pannell N; Ehlers M
BMC Infect Dis; 2022 Jun; 22(1):548. PubMed ID: 35705920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
